ClinicalTrials.gg
Active, not recruitingNCT06052865Updated Oct 22, 2026

Serial Brain MRI in Hospitalized Preterm Infants

An interventional study of SENSE-plus: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE II) program and SENSE: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE II) program in Preterm Birth Complication, sponsored by Brigham and Women's Hospital. Active, not recruiting at 1 site in United States. Open to participants aged 22 Weeks to 33 Weeks. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 2 years 11 months after the study started (first participant enrolled Sep 2020, registered Aug 2023).
Updated Oct 22, 2026Primary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Non-randomized
Ages
22 Weeks to 33 Weeks
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 742 studies in Premature Birth with a site in United States — 103 open to participants now, 136 under way, 9 of them phase 3. Premature Birth · United States.

Planned enrollment
283rd of 529
75 · median 85
Started
2020
with 31 others
No phase
357 of 742
52 open now
Primary completion
2027-09
later than 85 of 135 live
Registered
670th of 742
by date

Among the 742 studies in Premature Birth with a site in United States, this one is the 283rd largest by planned enrollment of the 529 interventional ones that give a count, is one of 32 that started in 2020, is one of 357 with no phase, reaches primary completion later than 85 of the 135 other live ones, and was the 670th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

103 of the 742 studies in Premature Birth with a site in United States are open now. Recruiting first, the newest first:

98 more — sign in →

All 103 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 22 Weeks to 33 Weeks · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 742 studies in Premature Birth with a site in United States, or all of them as a file.
02

Study summary

The purpose of this research study is to use serial magnetic resonance imaging (MRI) to define the timing and factors associated with brain injury as well as the pattern of brain growth of very preterm infants during hospitalization in the neonatal intensive care unit (NICU). In addition, the goal is to utilize early MRI to risk-stratify preterm infants and tailor rehabilitative interventions according to risk in order to explore associations between NICU rehabilitative intervention and short- and long-term outcomes of preterm infants.

Read the detailed description

Neurological adverse outcomes of very preterm birth can range from severe, including cerebral palsy, hearing and vision impairments, language disorders and learning disability, to less severe, such as developmental coordination disorders, fine motor control deficits, and mild cognitive impairments. While there are numerous factors, such as birth weight, gestational age, interventricular hemorrhage, and bronchopulmonary dysplasia, that have been shown to be associated with neurobehavioral impairments, the underlying neural mechanisms leading to these impairments are not yet understood. In the unit where this study is conducted, the standard of care is that babies born extremely preterm, or those born very preterm with additional clinical risk generally undergo a term equivalent age magnetic resonance imaging (MRI). However, given the limited understanding of the etiology of many neuronal disorders particularly in preterm born infants, findings on these term MRIs can be presented to families with many unanswered questions in terms of causation and implication for future development.

The few previous studies undertaken to better understand the etiology of brain injuries have used longitudinal serial imaging of preterm infants' brain during their NICU stays to look at trajectories of brain structural growth and the development of brain injury. One study found profuse increases in cortical grey matter growth rates that were accompanied by decreases in relative unmyelinated white matter growth rates. Another study found that the most common term equivalent finding associated with preterm birth was diffuse white matter abnormality, although causation and factors associated with these growth alterations and injuries are yet to be fully understood. The main limitation of both serial imaging studies is the limited number of scans per patient that were performed. The average number of scans per infant for both studies was around 2, which often corresponded to one at birth and one at term equivalent age (prior to NICU discharge), and did not provide sufficient information to comprehensively characterize the pattern of brain growth and development in this population.

One study investigated the structure-function relationship in preterm infants between MRI and clinical measures of motor, neurological and neurobehavioral capacity. Researchers found strong associations between the General Movements Assessment, Hammersmith Neonatal Neurological Examination, NICU Neonatal Neurobehavioral Scale, Premie-Neuro, and Test of Infant Motor Performance that correlated with the early and term-equivalent MRI. Based on a review of 88 articles that evaluated sensory-based interventions integrated in the care of very preterm infants in the NICU, nurturing interventions were noted to correlate with improved infant development and lower rates of maternal stress.

One such evidence-based multisensory program for hospitalized preterm infants is the SENSE II Program: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE II). The SENSE II program was developed to engage parents in consistently providing positive, developmentally appropriate sensory exposures to high-risk infants in the NICU every day of hospitalization. The SENSE II program includes specific doses and targeted timing (based on postmenstrual age) of evidence-based interventions of auditory, tactile, vestibular, kinesthetic, olfactory, and visual exposures to be conducted daily through hospitalization for preterm infants. The program also comprises a curated collection of parent educational materials aimed at guiding parents on infant sensory development, parenting in the NICU, and coaches families how to tailor nurturing interventions contingently upon infant responses and tolerance.

While these previous studies using serial imaging techniques provide a great foundation to understand individual brain development in the preterm infant, the lack of systematic regular serial MRI scans over the course of the entire NICU stay leaves room for future investigations to define the timing and factors associated with brain injury, as well as the pattern of brain growth in the preterm infant over the course of NICU the hospitalization. Newer imaging analysis methods are now available that allow regional brain volumes to be studied, which was not previously possible. Also, transporting small infants out of the NICU to the MRI scanner was a major barrier to carrying out serial studies without risk. This can now be overcome by new in-NICU MRI scanning technologies. As such, the Aspect Embrace Neonatal MRI System is an FDA-approved device which uses innovative technology to safely and effectively image infants within the NICU care environment. This type of in-NICU MRI scanner is available at this study site, specifically designed for infant neuroimaging and featuring a built-in incubator, self-contained magnet, and continuous video monitoring.

The present study plans to enroll very preterm infants who will receive brain MRI scans approximately every 2 weeks from enrollment until term-equivalent age, with an anticipated total of at least 3 brain scans, to monitor brain growth and evolution of injury throughout NICU hospitalization. Exposed infants will be categorized into two exposure groups (group 1: low-risk, and group 2: high-risk) based on the degree of neurological injury detected on early brain magnetic resonance imaging at study enrollment. Infants in the exposure groups will be compared with a reference group (group 3: unexposed). The primary outcome of this study consists of characterization of brain growth and development among preterm infants receiving NICU-based neuropromotive interventions compared to preterm infants receiving the standard of care at term-equivalent. Secondary outcomes include measures of infant neurodevelopment and parent-reported infant and family functioning at NICU discharge and at two years of age.

03

Conditions studied

  • Preterm Birth Complication

Keywords

  • preterm
  • brain injury
  • neonatal rehabilitation
04

Who can participate

Ages eligible
22 Weeks to 33 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • currently admitted to the BWH NICU
  • born before 33 weeks completed gestational age
  • birth weight 0.5-4.5 kg
  • is stable condition per clinical care team

Exclusion criteria

Exclusion

  • confirmed or suspected congenital anomaly or genetic syndrome
  • congenital TORCH infection
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
75 participants (estimated)

Study arms

  • Experimental
    Exposed: High neurological risk

    25 very preterm infants with advanced neurological injury

    Behavioral: SENSE-plus: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE II) program

  • Experimental
    Exposed: Low neurological risk

    25 very preterm infants with low/no neurological injury

    Behavioral: SENSE: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE II) program

  • Other
    Reference/ Standard of care

    25 very preterm infants with no study exposure/ standard of care

    Other: Reference/ Standard of care

Interventions

  • BehavioralSENSE-plus: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE II) program

    The SENSE II program was developed to engage parents in consistently providing positive, developmentally appropriate sensory exposures to their high-risk infants in the NICU every day of hospitalization. The SENSE II program includes specific doses and targeted timing (based on postmenstrual age) of evidence-based interventions of auditory, tactile, vestibular, kinesthetic, olfactory, and visual exposures to be conducted daily through hospitalization for preterm infants. Additionally, for very preterm infants with advanced neurological injury, additional 1-2 sessions of weekly motor therapy are added to the SENSE-II program

    Also known as: SENSE-plus

  • BehavioralSENSE: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE II) program

    The SENSE II program was developed to engage parents in consistently providing positive, developmentally appropriate sensory exposures to their high-risk infants in the NICU every day of hospitalization. The SENSE II program includes specific doses and targeted timing (based on postmenstrual age) of evidence-based interventions of auditory, tactile, vestibular, kinesthetic, olfactory, and visual exposures to be conducted daily through hospitalization for preterm infants.

    Also known as: SENSE

  • OtherReference/ Standard of care

    Infants in the Unexposed group receive the NICU standard of developmental care throughout hospitalization.

    Also known as: NICU care

06

What researchers measure

Primary outcomes

  1. Incidence and severity of brain injury on term equivalent brain MRI in very preterm infants

    Term equivalent brain MRIs will be assessed to characterize brain injury, including elements of: white matter abnormalities, cortical gray matter abnormalities, deep gray matter abnormalities, and cerebellar abnormalities. A total (global) brain injury score will be calculated as the sum of regional brain abnormalities total scores, with higher scores indicating more advanced level of injury as per the established scoring system for hospitalized preterm infants published by Kidokoro et al. The score will reveal the following categories for brain injury: no injury (total score 0-3), mild injury (score 4-7), or moderate-severe injury (total score 8 or above).

    Time frame: 3 months, average length of hospitalization for very preterm born infants

  2. Incidence and severity of white matter injury on early brain MRI before term-equivalent age for very preterm infants

    Enrolled infants will undergo at least 2 early brain MRIs before term-equivalent age during the NICU hospitalization. Presence or absence of white matter injury on early brain MRIs will be categorized as follows: normal (no white matter lesions), minimal (3 or fewer areas of T1 signal abnormality), or moderate-severe (\> 3 areas of T1 signal abnormality)

    Time frame: 3 months, average length of hospitalization for very preterm born infants

Secondary outcomes

  1. Standardized assessment of developmental performance across multiple areas (cognitive, language, motor) at 2 years corrected age

    General developmental skills will be assessed using the Bayley Scales of Infant and Toddler Development 4th Edition, which will be administered by a licensed clinical psychologist at 2 years corrected age. This assessment will provide standard scores and percentiles for each patient's performance in each of these domains: cognitive, language, motor. Scores will then be analyzed and presented as Average/Means and Standard Deviations for each study group, and performance among groups will be compared. For each of the Bayley assessment categories, the Average or Mean is considered to be 100, with a 1SD interval of 90-110, where higher scores represent better performance.

    Time frame: Up to 2 years corrected age

  2. Parent-reported child developmental performance (optional parent questionnaire)

    Child developmental performance measures will be collected with parent questionnaires given to parents at discharge and in follow-up up at 2 years corrected age. This will be assessed using The Ages and Stages Questionnaire, using the age-appropriate version. The ASQ scores will be compared with published referenced norms for age as per the Ages and Stages Questionnaire manual. Scores in each subdomain range on a scale from 0 (minimum) to 60 (maximum), with higher scores representing better performance.

    Time frame: Up to 2 years corrected age

  3. Parent-reported child risk for autism (optional parent questionnaire)

    The Modified Checklist for Autism-Revised (M-CHAT R) in Toddlers is a parent-report questionnaire that screens for behaviors commonly found in children with Autism Spectrum Disorders. Scoring will be performed as per published American Academy of Pediatrics guidelines, with higher scores representing a higher risk for autism. The risk categories will be classified as follows: score of 0-2 (non-critical items): "Low risk"; score of 3-6: "Medium risk" (or ≥2 critical items on M-CHAT), and score of 8-20: "High risk".

    Time frame: 2 years corrected age

  4. Incidence of parental stress (optional parent questionnaire)

    The Parental Stress Scale (PSS) or Parental Stress Scale (PSS):NICU is a questionnaire assessing parents' feelings about their parenting role, exploring both positive aspects (e.g. emotional benefits, personal development) and negative aspects of parenthood (e.g. demands on resources, feelings of stress). Each item is graded on a Likert scale from 1-5, with responses coded as per published scoring instructions. Parental stress scores range from 18 to 90, with lower scores indicating lower levels of parental stress.

    Time frame: Up to child's 2 years corrected age

  5. Parent sense of competency (optional parent questionnaire)

    The Parent Sense of Competency Scale (PSOC) is a 17 item scale. Each item is rated on a 6 point Likert scale anchored by 1 = "Strongly Disagree" and 6 = "Strongly Agree". Several items on the PSOC are reverse coded as per poublished guidelines. A higher score indicates a higher parenting sense of competency. There are no average scores or 'cut-off's' for this tool.

    Time frame: Up to child's 2 years corrected age

07

Study locations

1 site
08

References and documents

Publications

  • Pineda R, Wallendorf M, Smith J. A pilot study demonstrating the impact of the supporting and enhancing NICU sensory experiences (SENSE) program on the mother and infant. Early Hum Dev. 2020 May;144:105000. doi: 10.1016/j.earlhumdev.2020.105000. Epub 2020 Mar 6. PubMed 32151905 ↗
  • Als H, Duffy FH, McAnulty GB, Rivkin MJ, Vajapeyam S, Mulkern RV, Warfield SK, Huppi PS, Butler SC, Conneman N, Fischer C, Eichenwald EC. Early experience alters brain function and structure. Pediatrics. 2004 Apr;113(4):846-57. doi: 10.1542/peds.113.4.846. PubMed 15060237 ↗
  • Pineda RG, Neil J, Dierker D, Smyser CD, Wallendorf M, Kidokoro H, Reynolds LC, Walker S, Rogers C, Mathur AM, Van Essen DC, Inder T. Alterations in brain structure and neurodevelopmental outcome in preterm infants hospitalized in different neonatal intensive care unit environments. J Pediatr. 2014 Jan;164(1):52-60.e2. doi: 10.1016/j.jpeds.2013.08.047. Epub 2013 Oct 17. PubMed 24139564 ↗
  • Pineda R, Raney M, Smith J. Supporting and enhancing NICU sensory experiences (SENSE): Defining developmentally-appropriate sensory exposures for high-risk infants. Early Hum Dev. 2019 Jun;133:29-35. doi: 10.1016/j.earlhumdev.2019.04.012. Epub 2019 May 1. PubMed 31054467 ↗
  • Thiim KR, Singh E, Mukundan S, Grant PE, Yang E, El-Dib M, Inder TE. Clinical experience with an in-NICU magnetic resonance imaging system. J Perinatol. 2022 Jul;42(7):873-879. doi: 10.1038/s41372-022-01387-5. Epub 2022 Apr 22. PubMed 35459908 ↗
  • Matthews LG, Walsh BH, Knutsen C, Neil JJ, Smyser CD, Rogers CE, Inder TE. Brain growth in the NICU: critical periods of tissue-specific expansion. Pediatr Res. 2018 May;83(5):976-981. doi: 10.1038/pr.2018.4. Epub 2018 Feb 7. PubMed 29320484 ↗
  • Dyet LE, Kennea N, Counsell SJ, Maalouf EF, Ajayi-Obe M, Duggan PJ, Harrison M, Allsop JM, Hajnal J, Herlihy AH, Edwards B, Laroche S, Cowan FM, Rutherford MA, Edwards AD. Natural history of brain lesions in extremely preterm infants studied with serial magnetic resonance imaging from birth and neurodevelopmental assessment. Pediatrics. 2006 Aug;118(2):536-48. doi: 10.1542/peds.2005-1866. PubMed 16882805 ↗
  • Kidokoro H, Anderson PJ, Doyle LW, Woodward LJ, Neil JJ, Inder TE. Brain injury and altered brain growth in preterm infants: predictors and prognosis. Pediatrics. 2014 Aug;134(2):e444-53. doi: 10.1542/peds.2013-2336. PubMed 25070300 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2020 (actual). Primary completion is estimated for Sep 2027, 83 months after the start.

Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 83 months is above that.

Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

Primary completion moved once since we started tracking on Sep 25, 2026: Sep 2026 → Sep 2027, on Oct 22, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 30, 2023
First posted
Sep 25, 2023
StartActual
Sep 14, 2020
Primary completionEst.
Sep 1, 2027was Sep 2026
CompletionEst.
Sep 14, 2029
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 1, 2026→Sep 1, 2027
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Primary completion Sep 1, 2026→Sep 1, 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06052865
Collaborators
POM Wonderful LLC
Responsible party
Carmina Erdei, MD (Neonatologist, Brigham and Women's Hospital) — Principal investigator
First posted
Sep 25, 2023
Start date
Sep 14, 2020
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 14, 2029 (estimated)
Last update
Oct 22, 2026

Study contacts

Carmina Erdei, MD
principal investigator · Brigham and Women's Hospital and Harvard Medical School

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion